Vogt Frederick G Insider Trades

Insider Trading History

Track insider trading activity for Vogt Frederick G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $891k 235,000 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 235,000 shares
$5.41
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $2.01M 529,538 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123k 26,755 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $2.11M 556,293 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$286k 62,493 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $474k 125,007 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$286k 62,493 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.87M 493,800 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$86.4k 22,809 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $632k 166,675 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 52,087 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.96M 516,609 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 52,087 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $39.5k 10,418 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.2k 10,417 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.76M 464,522 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.47k 4,426 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.78M 468,948 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.2k 10,417 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $790k 208,344 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$92.9k 41,669 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.8M 476,232 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$92.9k 41,669 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.74M 458,531 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.5k 17,701 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.65M 434,563 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$48.5k 22,127 shares
$2.19
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.73M 456,690 shares
Last Trade
Sep 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 52,086 shares
$2.19
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.62M 426,731 shares
Last Trade
Jun 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$91.7k 52,085 shares
$1.76
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.53M 404,604 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.9k 22,127 shares
$1.76
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.42M 374,646 shares
Last Trade
May 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.3k 25,000 shares
$1.69
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $711k 187,500 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$759k 187,500 shares
$4.05
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Interim CEO & General Counsel
Holding Value $1.69M 445,059 shares
Last Trade
Mar 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$905k 223,943 shares
$4.04
$3.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up